Although speech disorder is frequently an early and prominent clinical feature of Parkinson's disease (PD) as well as atypical parkinsonian syndromes (APS) such as progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), there is a lack of objective and quantitative evidence to verify whether any specific speech characteristics allow differentiation between PD, PSP and MSA. Speech samples were acquired from 77 subjects including 15 PD, 12 PSP, 13 MSA and 37 healthy controls. The accurate differential diagnosis of dysarthria subtypes was based on the quantitative acoustic analysis of 16 speech dimensions. Dysarthria was uniformly present in all parkinsonian patients but was more severe in PSP and MSA than in PD. Whilst PD speakers manifested pure hypokinetic dysarthria, ataxic components were more affected in MSA whilst PSP subjects demonstrated severe deficits in hypokinetic and spastic elements of dysarthria. Dysarthria in PSP was dominated by increased dysfluency, decreased slow rate, inappropriate silences, deficits in vowel articulation and harsh voice quality whereas MSA by pitch fluctuations, excess intensity variations, prolonged phonemes, vocal tremor and strained-strangled voice quality. Objective speech measurements were able to discriminate between APS and PD with 95% accuracy and between PSP and MSA with 75% accuracy. Dysarthria severity in APS was related to overall disease severity (r = 0.54, p = 0.006). Dysarthria with various combinations of hypokinetic, spastic and ataxic components reflects differing pathophysiology in PD, PSP and MSA. Thus, motor speech examination may provide useful information in the evaluation of these diseases with similar manifestations.

Department of Circuit Theory Faculty of Electrical Engineering Czech Technical University Prague Technická 2 160 00 Prague 6 Czech Republic

Zobrazit více v PubMed

Neurol India. 2008 Apr-Jun;56(2):122-6 PubMed

J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4 PubMed

Arch Neurol. 2001 Feb;58(2):265-9 PubMed

Parkinsonism Relat Disord. 2014 Aug;20(8):855-61 PubMed

Neurology. 2008 Aug 26;71(9):670-6 PubMed

Neurology. 1993 Mar;43(3 Pt 1):563-6 PubMed

J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):319-24 PubMed

J Acoust Soc Am. 2013 Sep;134(3):2171-81 PubMed

J Voice. 2011 Nov;25(6):725-31 PubMed

Lancet. 1999 Nov 20;354(9192):1771-5 PubMed

Neurology. 1996 Jul;47(1):1-9 PubMed

J Neural Transm (Vienna). 2014 Jun;121(6):655-64 PubMed

Mov Disord. 2013 Nov;28(13):1816-22 PubMed

Behav Neurol. 1998;11(3):131-137 PubMed

Ann N Y Acad Sci. 2011 Jun;1228:93-108 PubMed

Brain. 2015 Mar;138(Pt 3):712-25 PubMed

Mov Disord. 2001 May;16(3):562-5 PubMed

J Speech Hear Res. 1969 Jun;12(2):246-69 PubMed

J Acoust Soc Am. 2011 Jan;129(1):350-67 PubMed

J Neural Transm (Vienna). 2015 Aug;122(8):1135-42 PubMed

PLoS One. 2011;6(8):e22293 PubMed

J Neural Transm (Vienna). 2009 Feb;116(2):167-9 PubMed

Parkinsonism Relat Disord. 2015 Feb;21(2):150-3 PubMed

Neuropharmacology. 2011 Sep;61(4):753-60 PubMed

Arch Neurol. 1996 Jun;53(6):545-8 PubMed

Mov Disord. 2011 May;26(6):1083-95 PubMed

J Acoust Soc Am. 2002 Dec;112(6):3022-30 PubMed

J Neural Transm (Vienna). 2014 Dec;121(12):1529-39 PubMed

Mov Disord. 2011 Aug 15;26(10):1951-2 PubMed

Lancet Neurol. 2010 Feb;9(2):149-58 PubMed

Neurology. 2003 Mar 25;60(6):910-6 PubMed

Mov Disord. 2008 Mar 15;23(4):574-80 PubMed

Speech acoustic indices for differential diagnosis between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy

Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson's disease

Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy

Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation

Automatic Evaluation of Speech Rhythm Instability and Acceleration in Dysarthrias Associated with Basal Ganglia Dysfunction